(MENAFN- IMARC Group)
IMARC Group has published a market research report titled“ United States Bioanalytical Testing Services Market Report by Molecule Type (Small Molecule, Large Molecule), Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Others), Workflow (Sample Preparation, Sample Analysis, and Others), and Region 2024-2032 “, United States bioanalytical testing services market size is projected to exhibit a growth rate (CAGR) of 8.50% during
2024-2032.
Bioanalytical testing services involve the analysis of biological samples to quantify the presence of drugs, metabolites, and biomarkers. They rely on various techniques, such as chromatography, mass spectrometry, and immunoassays, to detect and measure molecules within biological matrices like blood, plasma, urine, tissue, or saliva. They help in identifying potential safety concerns by detecting and quantifying drug metabolites, impurities, and toxic compounds in biological samples. They ensure the quality and consistency of pharmaceutical products by verifying their composition, potency, and purity. They are utilized in the pharmaceutical and biotechnology industries during the development and testing of drugs, and in academic and clinical research settings.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-bioanalytical-testing-services-market/requestsample
United States Bioanalytical Testing Services Market Trends and Drivers
At present, the rising number of drug development programs by pharmaceutical and biotechnology companies represents one of the key factors propelling the market growth in the United States. Moreover, regulatory agencies like the Food and Drug Administration (FDA) require comprehensive bioanalytical data to assess the safety, efficacy, and quality of pharmaceutical products is catalyzing the demand for bioanalytical testing services for supporting drug approval applications and post-marketing surveillance. In addition, ongoing advancements in analytical techniques, such as liquid chromatography-mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS/MS), and immunoassays, that enhance the sensitivity, specificity, and throughput of bioanalytical testing methods are supporting the growth of the market in the US. Besides this, the increasing prevalence of chronic diseases like cancer, cardiovascular disorders, and autoimmune conditions is driving the demand for bioanalytical testing services for biomarker discovery, disease diagnosis, and therapeutic monitoring. Additionally, outsourcing of bioanalytical testing services to contract research organizations (CROs) and specialized testing laboratories to streamline operations, reduce costs, and access specialized expertise is offering a favorable market outlook. Apart from this, the rising development and commercialization of biosimilar drugs and biological therapies are facilitating the growth of the market in the country. Furthermore, the increasing utilization of bioanalytical testing services for point-of-care (POC) diagnostic and minimizing the resultant health and societal impact of the infection is stimulating the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Molecule Type Insights:
Small Molecule Large Molecule LC-MS Studies Immunoassays Others
Test Type Insights:
ADME PK PD Bioavailability Bioequivalence Others
Workflow Insights:
Sample Preparation Protein Precipitation Liquid-Liquid Extraction Solid Phase Extraction
Sample Analysis Hyphenated Technique Chromatographic Technique Electrophoresis Ligand Binding Assay Mass Spectrometry Nuclear Magnetic Resonance
Others
Regional Insights:
Northeast Midwest South West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN04032024004122016232ID1107929598
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.